Meiqi Cheng
机构：Hubei Polytechnic University, Huangshi Central Hospital · ORCID：0009-0005-4113-9687
发表论文 11 篇 · 总被引 191 次 · h-index 6
代表论文
- Development of Mannosylated Lipid Nanoparticles for mRNA Cancer Vaccine with High Antigen Presentation Efficiency and Immunomodulatory Capability (2024 · Angewandte Chemie International Edition · 被引 69)
- Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation (2025 · Nature Materials · 被引 50)
- Development of Organ Targeting Lipid Nanoparticles with Low Immunogenicity and Their Application in the Treatment of Pulmonary Fibrosis (2024 · Angewandte Chemie International Edition · 被引 26)
- Catalytic Hybrid Lipid Nanoparticles Potentiate Circle RNA-Based Cytokine Immunotherapy (2025 · ACS Nano · 被引 16)
- Development of Mannosylated Lipid Nanoparticles for mRNA Cancer Vaccine with High Antigen Presentation Efficiency and Immunomodulatory Capability (2024 · Angewandte Chemie · 被引 12)
- Topologically Engineered Supramolecular Cyclolipid Nanoparticles: A Custom-Tailored Delivery System for Inhaled Combination Therapy (2025 · Journal of the American Chemical Society · 被引 10)